Pembrolizumab,Vibostolimab,Favezelimab
merck
['mibc', 'pembro', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'blcsm']
pembrolizumab produces high dfs rates in bcg-unresponsive nmibc #blcsm #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.